The UK is set to expand a voluntary drug program for male prisoners struggling with persistent sexual urges, trialing medications from SSRIs to anti-androgens across 20 prisons by November—potentially scaling nationwide by 2028. While officials tout it as a targeted intervention to reduce reoffending, critics warn against mandatory use, citing risks of abuse, loss of trust, and flawed implementation. Experts stress the need for trained staff, psychological support, and voluntary participation to ensure effectiveness and ethical integrity.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
